Restoration of miR-34a in p53 deficient cells unexpectedly promotes the cell survival by increasing NFκB activity

Journal of Cellular Biochemistry

Volumn 113, Issue 9, 2012, Pages 2903-2908

  Tan, Jiali ^a   Fan, Li ^b   Mao, Jeremy J ^c   Chen, Bin ^a   Zheng, Liwei ^d   Zhang, Tao ^c   Li, Tong ^e   Duan, Jianmin ^a   Duan, Yinzhong ^b   Jin, Zuolin ^b   Kuang, Wei ^a  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c NewYork Presbyterian Hospital   (United States)

^d SICHUAN UNIVERSITY   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; cisplatin; miR 34a; NF B; p53; SIRT1

Indexed keywords

CISPLATIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 34A; PROTEIN P53; SIRTUIN 1;

APOPTOSIS; ARTICLE; CELL SURVIVAL; DNA DAMAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MICRORNAS; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84863653619     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24167     Document Type: Article

References (32)

1. Audrito V, Vaisitti T, Rossi D, Gottardi D, D'Arena G, Laurenti L, Gaidano G, Malavasi F, Deaglio S,. 2011. Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Cancer Res 71: 4473-4483.
2. Berman SD, Calo E, Landman AS, Danielian PS, Miller ES, West JC, Fonhoue BD, Caron A, Bronson R, Bouxsein ML, Mukherjee S, Lees JA,. 2008. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage. Proc Natl Acad Sci USA 105: 11851-11856.
3. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT,. 2007. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752.
4. Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, Yi S, Mucke L, Gan L,. 2005. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 280: 40364-40374.
5. Chen LF, Mu Y, Greene WC,. 2002. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J 21: 6539-6548.
6. Fearon ER, Vogelstein B,. 1990. A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
7. Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, Deguchi T, Ito M,. 2008. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun 377: 114-119.
8. Garrouste F, Remacle-Bonnet M, Fauriat C, Marvaldi J, Luis J, Pommier G,. 2002. Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism. Cell Death Differ 9: 768-779.
9. Hanahan D, Weinberg RA,. 2000. The hallmarks of cancer. Cell 100: 57-70.
10. Karin M, Lin A,. 2002. NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227.
11. Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S, Benkirane M,. 2003. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem 278: 2758-2766.
12. Mantovani A, Allavena P, Sica A, Balkwill F,. 2008. Cancer-related inflammation. Nature 454: 436-444.
13. Merkel O, Asslaber D, Pinon JD, Egle A, Greil R,. 2010. Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia. Cell Cycle 9: 2764-2768.
14. Michan S, Sinclair D,. 2007. Sirtuins in mammals: Insights into their biological function. Biochem J 404: 1-13.
15. Park SM, Gaur AB, Lengyel E, Peter ME,. 2008. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907.
16. Rahman S, Islam R,. 2011. Mammalian Sirt1: Insights on its biological functions. Cell Commun Signal 9: 11.
17. Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I,. 2008. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177: 861-870.
18. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M,. 2007. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743.
19. Saunders LR, Verdin E,. 2007. Sirtuins: Critical regulators at the crossroads between cancer and aging. Oncogene 26: 5489-5504.
20. Sotillo E, Laver T, Mellert H, Schelter JM, Cleary MA, McMahon S, Thomas-Tikhonenko A,. 2011. Myc overexpression brings out unexpected antiapoptotic effects of miR-34a. Oncogene 30: 2587-2594.
21. Sun F, Fu H, Liu Q, Tie Y, Zhu J, Xing R, Sun Z, Zheng X,. 2008. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett 582: 1564-1568.
22. Tan J, Kuang W, Jin Z, Jin F, Xu L, Yu Q, Kong L, Zeng G, Yuan X, Duan Y,. 2009. Inhibition of NFkappaB by activated c-Jun NH2 terminal kinase 1 acts as a switch for C2C12 cell death under excessive stretch. Apoptosis 14: 764-770.
23. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H,. 2007. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 104: 15472-15477.
24. Tong AW, Nemunaitis J,. 2008. Modulation of miRNA activity in human cancer: A new paradigm for cancer gene therapy? Cancer Gene Ther 15: 341-355.
25. Wang X, Liu P, Zhu H, Xu Y, Ma C, Dai X, Huang L, Liu Y, Zhang L, Qin C,. 2009. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull 80: 268-273.
26. Wee KB, Surana U, Aguda BD,. 2009. Oscillations of the p53-Akt network: Implications on cell survival and death. PLoS One 4: e4407.
27. Wei JS, Song YK, Durinck S, Chen QR, Cheuk AT, Tsang P, Zhang Q, Thiele CJ, Slack A, Shohet J, Khan J,. 2008. The MYCN oncogene is a direct target of miR-34a. Oncogene 27: 5204-5213.
28. Yamakuchi M, Ferlito M, Lowenstein CJ,. 2008. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 105: 13421-13426.
29. Yamakuchi M, Lowenstein CJ,. 2009. MiR-34, SIRT1 and p53: The feedback loop. Cell Cycle 8: 712-715.
30. Yang SR, Wright J, Bauter M, Seweryniak K, Kode A, Rahman I,. 2007. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: Implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol 292: L567-L576.
31. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW,. 2004. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23: 2369-2380.
32. Zhao T, Li J, Chen AF,. 2010. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metab 299: E110-E116.